XLV241122P124000
- 0.00
- 0.000.00%
The Health Care Select Sector SPDR® Fund Newsroom
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Amid Fears of Russian Escalation
Leading And Lagging Sectors For November 19, 2024
Merck Says Injectable Keytruda Succeeded in Late-stage Trial
AbbVie Snaps Eight Straight Sessions of Losses
Johnson & Johnson Announced Topline Results From ICONIC-LEAD, A Pivotal Phase 3 Investigational Study Of Icotrokinra, The First Targeted Oral Peptide That Selectively Blocks The IL-23 Receptor, In Adults And Adolescents 12 Years Of Age And Older With...
Monday Market Slow but Steady, Trump Buying Crypto Firm | Wall Street Today
US Stocks Rebound, Tesla Rallies, Bitcoin Soars Above $92,000: What's Driving Markets Monday?
Weekly ETF Flows: SPY Records Inflows, Bitcoin Funds See Large Influx of Capital
Monday Opens to S&P 500 Climb, Dow Slides as Eyes Look Toward Nvidia | Live Stock
Eli Lilly's Zepbound/Mounjaro Shows Cardiovascular Benefits In Patients With Obesity-Related Heart Failure
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Monday as Investors Refocus on Earnings
Eli Lilly's Tirzepatide Cuts Risk of Worsening Heart Failure in HFpEF, Obese Patients
Dow Tumbles Over 300 Points Following Economic Reports, Nvidia, Microsoft Decline: Fear & Greed Index Moves To 'Neutral' Zone
Hedge Funds Were Net Buyers of Financials, Healthcare for Week: Goldman Sachs
This Momentum Indicator Says the S&P Won't Peak Until Next Year
Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth
The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.
Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.
First Mpox Case Linked to African Outbreak Reported in U.S.
Trending Stocks This Week as Wall Street Sells off Amid Fed Remarks